ASTRIA THERAPEUTICS INC (ATXS) Forecast, Price Target & Analyst Ratings

NASDAQ:ATXS • US04635X1028

Current stock price

12.58 USD
+0.08 (+0.64%)
At close:
12.58 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ASTRIA THERAPEUTICS INC (ATXS).

Forecast Snapshot

Consensus Price Target

Price Target
$21.62
+ 71.89% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 9, 2026
Period
Q4 / 2025
EPS Estimate
-$0.49
Revenue Estimate
8.16M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
71.43%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.62
Upside
+ 71.89%
From current price of $12.58 to mean target of $21.62, Based on 14 analyst forecasts
Low
$13.13
Median
$13.26
High
$36.75

Price Target Revisions

1 Month
0.00%
3 Months
-17.94%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ATXS. The average price target is 21.62 USD. This implies a price increase of 71.89% is expected in the next year compared to the current price of 12.58.
The average price target has been revised downward by 17.94% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ATXS Current Analyst RatingATXS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ATXS Historical Analyst RatingsATXS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
71.43%
ATXS was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about ATXS.
In the previous month the buy percentage consensus was at a similar level.
ATXS was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-12Cantor FitzgeraldDowngrade Overweight -> Neutral
2025-10-16HC Wainwright & Co.Downgrade Buy -> Neutral
2025-10-15JMP SecuritiesDowngrade Market Outperform -> Market Perform
2025-10-15WedbushDowngrade Outperform -> Neutral
2025-10-14JefferiesDowngrade Buy -> Hold
2025-09-17Cantor FitzgeraldReiterate Overweight -> Overweight
2025-09-17HC Wainwright & Co.Maintains Buy -> Buy
2025-08-13JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-08-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-14Cantor FitzgeraldReiterate Overweight -> Overweight
2025-04-29Cantor FitzgeraldInitiate Overweight
2025-03-12WedbushMaintains Outperform -> Outperform
2025-03-11HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-03Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-02-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-31JMP SecuritiesInitiate Market Outperform
2025-01-23HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-14OppenheimerMaintains Outperform -> Outperform
2024-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-27HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-13OppenheimerMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 9, 2026
Period
Q4 / 2025
EPS Estimate
-$0.49
Revenue Estimate
8.16M
Revenue Q2Q
N/A
EPS Q2Q
-144.97%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
166.67%
Revenue (3 Months)
166.67%
EPS (1 Month)
13.32%
EPS (3 Months)
13.05%

Next Earnings Summary

ATXS is expected to report earnings on 3/9/2026. The consensus EPS estimate for the next earnings is -0.49 USD and the consensus revenue estimate is 8.16M USD.
The next earnings revenue estimate has been revised upward by 166.67% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ATXS revenue by date.ATXS revenue by date.
500K
-100.00%		8.74M3.57M
-59.15%		4.264M
19.44%		60.85M
1,327.06%		241.65M
297.12%		448.51M
85.60%		627.47M
39.90%		792.02M
26.22%		685.89M
-13.40%
EBITDA
YoY % growth
ATXS ebitda by date.ATXS ebitda by date.
-31.46M-35.16M
-11.76%		-26.79M
23.81%		N/A
2.02%		N/A
-3.09%		-35.904M
-32.68%		-197.982M
-451.42%		-52.938M
73.26%		-71.298M
-34.68%		-114.24M
-60.23%		-162.282M
-42.05%		-182.784M
-12.63%		-200.226M
-9.54%		-209.712M
-4.74%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ATXS ebit by date.ATXS ebit by date.
-31.66M-35.56M
-12.32%		-27.09M
23.82%		-27.475M
2.66%		-28.27M
-2.73%		-38.148M
-38.21%		-197.657M
-420.78%		-54M
72.56%		-80.417M
-26.79%		-115.558M
-64.46%		-142.552M
-27.78%		-158.677M
-11.31%		-162.414M
-2.36%		-140.319M
13.60%		-3.929M
97.20%		110.39M
2,909.35%		232.86M
110.94%		346.65M
48.87%		350.6M
1.14%
Operating Margin
ATXS operating margin by date.ATXS operating margin by date.
N/AN/A-5,418.00%N/AN/AN/AN/AN/AN/AN/A-1,631.03%-4,444.73%-3,808.95%-230.60%-1.63%24.61%37.11%43.77%51.12%
EPS
YoY % growth
ATXS eps by date.ATXS eps by date.
N/A-133.80
42.05%		-76.80
42.60%		-30.15
46.09%		-14.78
65.94%		-11.51
13.62%		-39.19
-17.49%		-3.58
74.63%		-2.32
33.33%		-1.69
40.91%		-2.20
-53.66%		-2.27
-3.42%		-2.01
11.72%		-1.98
1.53%		-0.83
58.18%		-0.95
-14.81%		1.13
218.82%		2.29
103.17%		3.41
48.78%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.49
-144.97%		-0.59
-1.25%		-0.60
-5.22%		-0.61
-11.55%		-0.63
-28.25%		-0.79
-34.26%		-0.65
-7.99%		-0.69
-11.89%		-0.72
-15.26%
Revenue
Q2Q % growth		8.16M1.02M1.02M1.02M
44.48%		1.02M
-87.50%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-46.92M
-52.82%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-30.294M
-2.38%		-36.887M
0.29%		-37.358M
-4.29%		-37.867M
-11.03%		-38.722M
-27.82%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ATXS Yearly Revenue VS EstimatesATXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
ATXS Yearly EPS VS EstimatesATXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -50 -100 -150 -200

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-11.95%
EPS Next 5 Year
7.30%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-20.11%
EBIT Next 5 Year
-16.07%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ASTRIA THERAPEUTICS INC / ATXS Forecast FAQ

What do analysts expect the price target to be for ASTRIA THERAPEUTICS INC (ATXS)?

14 analysts have analysed ATXS and the average price target is 21.62 USD. This implies a price increase of 71.89% is expected in the next year compared to the current price of 12.58.

Can you provide the upcoming earnings date for ASTRIA THERAPEUTICS INC?

ASTRIA THERAPEUTICS INC (ATXS) will report earnings on 2026-03-09, after the market close.

What are the consensus estimates for ASTRIA THERAPEUTICS INC (ATXS) next earnings?

The consensus EPS estimate for the next earnings of ASTRIA THERAPEUTICS INC (ATXS) is -0.49 USD and the consensus revenue estimate is 8.16M USD.